2012
DOI: 10.1159/000336673
|View full text |Cite
|
Sign up to set email alerts
|

Securing the Data Economy: Translating Privacy and Enacting Security in the Development of DataSHIELD

Abstract: Contemporary bioscience is seeing the emergence of a new data economy: with data as its fundamental unit of exchange. While sharing data within this new ‘economy’ provides many potential advantages, the sharing of individual data raises important social and ethical concerns. We examine ongoing development of one technology, DataSHIELD, which appears to elide privacy concerns about sharing data by enabling shared analysis while not actually sharing any individual-level data. We combine presentation of the devel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
22
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(23 citation statements)
references
References 39 publications
1
22
0
Order By: Relevance
“…Following initial proof-of-principle (Wolfson et al 2010;Jones et al 2012;Gaye et al 2014;Doiron et al 2013) a stable platform has been developed (available under a GPL3 license) and the legal, ethical and social issues arising from the DataSHIELD approach to the analysis of biomedical data have been reviewed Budin-Ljøsne et al 2014;Murtagh et al 2012Murtagh et al , 2016. DataSHIELD has been successfully piloted within two epidemiological projects in the FP7-funded BioSHaRE-EU consortium 7 -co-analysing phenotypic data from separately located European biobanks investigating i) healthy obesity comprising 10 biobanks with 99 phenotypic variables and ii) the effect of environmental determinants on health comprising five biobanks with 51 phenotypic variables and 14 environmental variables extracted from exposure models Zijlema et al 2016).…”
Section: Existing Applications Of Datashieldmentioning
confidence: 99%
“…Following initial proof-of-principle (Wolfson et al 2010;Jones et al 2012;Gaye et al 2014;Doiron et al 2013) a stable platform has been developed (available under a GPL3 license) and the legal, ethical and social issues arising from the DataSHIELD approach to the analysis of biomedical data have been reviewed Budin-Ljøsne et al 2014;Murtagh et al 2012Murtagh et al , 2016. DataSHIELD has been successfully piloted within two epidemiological projects in the FP7-funded BioSHaRE-EU consortium 7 -co-analysing phenotypic data from separately located European biobanks investigating i) healthy obesity comprising 10 biobanks with 99 phenotypic variables and ii) the effect of environmental determinants on health comprising five biobanks with 51 phenotypic variables and 14 environmental variables extracted from exposure models Zijlema et al 2016).…”
Section: Existing Applications Of Datashieldmentioning
confidence: 99%
“…In many circumstances, such as in fitting models based on maximizing a likelihood, the computations can be distributed, with aggregation limited to the intermediate results of calculations on local data, rather than raw data; see Murtagh et al (2012) for example. Indeed, sometimes distribution of the calculation among sites is necessary to share a heavy computational burden, as would be the case for fitting the alternating direction method of multipliers (ADMM) models of Boyd, Parikh, Chu, Peleato, and Eckstein (2011).…”
Section: Introductionmentioning
confidence: 99%
“…[1]. These collaborations present administrative, ethical, and legal challenges as the confidentiality of the identifiable data collected from participants must be protected and its sharing controlled through applicable legislation, guidance, ethics review, and data access mechanisms [2]. While such controls rightly provide protections, there is a perception that they may also limit access to data and may hinder the research process [3].…”
Section: Introductionmentioning
confidence: 99%
“…Terms reflecting between-study heterogeneity must typically be incorporated. Individual-level data are variously referred to as ‘individual patient data' by meta-analysts and as ‘micro-data' by bioinformaticians [2]. As an alternative, combined analysis may be based on study-level meta-analysis (SLMA).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation